THERIOPHARM
Entreprises (Petites et Moyennes Entreprises, Industrie)
www.linkedin.com/in/dr-ing-raphaël-duval-2763a4153Wavre, Belgique3 visites de profil
Détails
-
nanomedicine platforms
-
drug deliverys systems
-
molecular encapsulation
-
drug repurposing
-
drug combination
-
prebiotics
Domaines d'activité
Maladies infectieuses, préparation et innovation antimicrobienne
1. HORIZON HLTH 2027 01 DISEASE 05 – Novel small molecule antivirals for epidemic pathogens4. HORIZON HLTH 2027 01 DISEASE 08 – Innovative antimicrobials against resistant pathogens
Médecine de précision et personnalisée
2. HORIZON HLTH 2027 02 DISEASE 01 two stage – Innovative healthcare interventions for non communicable diseases3. HORIZON HLTH 2027 01 DISEASE 10 – Prevention and management of chronic non communicable diseases in children and youth (GACD)4. HORIZON MISS 2027 02 CANCER 01 – Functional genomics to reveal novel targets for cancer treatment5. HORIZON MISS 2027 02 CANCER 02 – Clinical research by Comprehensive Cancer Infrastructures
Représentants
CEO
THERIOPHARM